- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.79 Å
- Oligo State
- homo-dimer
- Ligands
- 7 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- 7 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
PEG.4: 4 residues within 4Å:- Chain A: W.54, S.55, V.57, W.58
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:V.57, A:V.57
- Water bridges: A:K.51
PEG.5: 7 residues within 4Å:- Chain A: M.405, H.406, N.409, C.521, V.522, N.525, Q.526
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:H.406, A:N.409, A:C.521, A:N.525, A:Q.526
PEG.6: 5 residues within 4Å:- Chain A: S.108, T.110, D.190, T.193, K.478
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:S.108
- Water bridges: A:T.193, A:R.221, A:K.478
PEG.13: 4 residues within 4Å:- Chain A: V.238, I.296, D.297, G.298
2 PLIP interactions:2 interactions with chain A- Water bridges: A:S.304, A:S.304
PEG.14: 7 residues within 4Å:- Chain A: R.242, V.246, L.256, N.257, S.258, D.259, L.262
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:R.242, A:S.258, A:D.259
PEG.18: 4 residues within 4Å:- Chain B: W.54, S.55, V.57, W.58
3 PLIP interactions:3 interactions with chain B- Water bridges: B:V.57, B:V.57, B:N.59
PEG.24: 4 residues within 4Å:- Chain B: V.238, I.296, D.297, G.298
1 PLIP interactions:1 interactions with chain B- Water bridges: B:V.238
- 8 x E1K: 6-chloranyl-10-methyl-1,2,3,4-tetrahydroacridin-10-ium-9-amine(Non-covalent)
E1K.7: 14 residues within 4Å:- Chain A: G.80, S.81, W.84, G.117, G.118, E.199, F.330, Y.334, W.432, I.439, H.440, G.441, Y.442
- Ligands: E1K.8
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:F.330, A:F.330, A:F.330, A:W.432
- Hydrogen bonds: A:H.440
- pi-Stacking: A:W.84, A:W.84, A:W.84, A:F.330
E1K.8: 10 residues within 4Å:- Chain A: W.84, G.117, G.118, Y.130, E.199, F.330, W.432, H.440, G.441
- Ligands: E1K.7
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:W.84, A:W.84, A:W.84
- Water bridges: A:W.84, A:W.84
- pi-Stacking: A:W.84, A:W.84, A:W.84, A:F.330
E1K.9: 5 residues within 4Å:- Chain A: Y.70, W.279, N.280, S.286
- Ligands: E1K.10
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:W.279, A:W.279, A:W.279
- Hydrogen bonds: A:S.286
- Water bridges: A:S.286
- pi-Stacking: A:W.279, A:W.279
E1K.10: 4 residues within 4Å:- Chain A: Q.74, D.285, Y.334
- Ligands: E1K.9
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:Y.334
- Halogen bonds: A:D.285
E1K.19: 14 residues within 4Å:- Chain B: G.80, S.81, W.84, G.117, G.118, E.199, F.330, Y.334, W.432, I.439, H.440, G.441, Y.442
- Ligands: E1K.20
9 PLIP interactions:9 interactions with chain B- Hydrophobic interactions: B:F.330, B:F.330, B:Y.334, B:W.432
- Hydrogen bonds: B:H.440
- pi-Stacking: B:W.84, B:W.84, B:W.84, B:F.330
E1K.20: 10 residues within 4Å:- Chain B: W.84, G.117, G.118, Y.130, E.199, F.330, W.432, H.440, G.441
- Ligands: E1K.19
7 PLIP interactions:7 interactions with chain B- Hydrophobic interactions: B:W.84
- Water bridges: B:W.84, B:W.84
- pi-Stacking: B:W.84, B:W.84, B:W.84, B:F.330
E1K.21: 5 residues within 4Å:- Chain B: Y.70, W.279, N.280, S.286
- Ligands: E1K.22
6 PLIP interactions:6 interactions with chain B- Hydrophobic interactions: B:W.279, B:W.279, B:W.279
- Hydrogen bonds: B:S.286
- pi-Stacking: B:W.279, B:W.279
E1K.22: 4 residues within 4Å:- Chain B: Y.70, Q.74, Y.334
- Ligands: E1K.21
1 PLIP interactions:1 interactions with chain B- Water bridges: B:Y.334
- 3 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Galdeano, C. et al., Increasing Polarity in Tacrine and Huprine Derivatives: Potent Anticholinesterase Agents for the Treatment of Myasthenia Gravis. Molecules (2018)
- Release Date
- 2018-04-04
- Peptides
- Acetylcholinesterase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.79 Å
- Oligo State
- homo-dimer
- Ligands
- 7 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- 7 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- 8 x E1K: 6-chloranyl-10-methyl-1,2,3,4-tetrahydroacridin-10-ium-9-amine(Non-covalent)
- 3 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Galdeano, C. et al., Increasing Polarity in Tacrine and Huprine Derivatives: Potent Anticholinesterase Agents for the Treatment of Myasthenia Gravis. Molecules (2018)
- Release Date
- 2018-04-04
- Peptides
- Acetylcholinesterase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B